Assignee
LUNG THERAPEUTICS INC
US·2 granted patents·5 pending applications·3 citations·filing 2019–2022
Top patents by PatentIndex Score
7 records- 0193US11787838B2Modified peptide fragments of CAV-1 protein and the use thereof in the treatment of fibrosisLUNG THERAPEUTICS INC·Filed 2022·Granted Oct 17, 2023·2 cites·27 claims
- 0280US11905336B2Modified peptide fragments of CAV-1 protein and the use thereof in the treatment of fibrosisLUNG THERAPEUTICS INC·Filed 2019·Granted Feb 20, 2024·1 cites·11 claims
- 0357US2024374585A1Epithelial sodium channel (enac) inhibitor conjugates and methods for use thereofLUNG THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0456US2022160814A1Compositions and methods for protecting type 2 alveolar epithelial cells (aec2)LUNG THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0556US2025041383A1Modified caveolin-1 peptides for the treatment of post-acute covid-19LUNG THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0652US2023226149A1Modified caveolin-1 peptides for the treatment of pathogen-induced lung injuryLUNG THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0747US2023159608A1Modified peptide fragments of cav-1 protein and uses thereofLUNG THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when LUNG THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →